Next Article in Journal
Scutellarein from Erigeron breviscapus Inhibits Apoptosis-Mediated Epithelial Barrier Disruption and Alleviates Cigarette Smoke-Induced Lung Injury
Previous Article in Journal
Herba Patriniae Component Linarin Induces Cell Cycle Arrest and Senescence in Non-Small-Cell Lung Cancer Associated with Cyclin A2 Downregulation
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceuticals
Volume 19
Issue 1
10.3390/ph19010112
pharmaceuticals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Pharmaceuticals 2025, 18(12), 1831.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Iacovitti et al. The Prevalence and Malignancy Risk of Breast Incidental Uptake Detected by PET/CT with Different Radiopharmaceuticals: An Updated Systematic Review and Meta-Analysis. Pharmaceuticals 2025, 18, 1831

by
Cesare Michele Iacovitti
1,
Andreea Marin
2,
Slavko Tasevski
3,
Chiara Martinello
1,
Marco Cuzzocrea
1,
Gaetano Paone
1,4,
Alessio Rizzo
5,
Domenico Albano
6 and
Giorgio Treglia
1,4,7,*
1
Division of Nuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland
2
Clinic of Nuclear Medicine, Central University Emergency Military Hospital “Dr. Carol Davila”, 10825 Bucharest, Romania
3
University Institute for Positron Emission Tomography, 1000 Skopje, North Macedonia
4
Faculty of Biomedical Sciences, Università della Svizzera Italiana, 6900 Lugano, Switzerland
5
Department of Nuclear Medicine, Candiolo Cancer Institute, FPO-IRCCS, 10060 Turin, Italy
6
Nuclear Medicine Department, ASST Spedali Civili, University of Brescia, 25123 Brescia, Italy
7
Faculty of Biology and Medicine, University of Lausanne, 1015 Lausanne, Switzerland
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2026, 19(1), 112; https://doi.org/10.3390/ph19010112
Submission received: 26 December 2025 / Accepted: 1 January 2026 / Published: 8 January 2026
Versions Notes

Text Correction

There was an error in the original publication [1]. There is no mention of Figure S1 or Table S1 in the Supplementary Materials.
Corrections have been made to Section 2.1. Review Protocol, Working Group, and Review Question, Paragraph 1, and Section 3.1. Literature Search, Paragraph 1, as below:
“This review followed a predefined protocol [8] and is reported in accordance with PRISMA 2020 (PRISMA checklist reported in Table S1) [9].”
“The selection process is summarized in Figures 1 and S1.”

Missing Supplementary Materials

In the original publication [1], Supplementary Materials was not included. The Supplementary Materials part should read:
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Iacovitti, C.M.; Marin, A.; Tasevski, S.; Martinello, C.; Cuzzocrea, M.; Paone, G.; Rizzo, A.; Albano, D.; Treglia, G. The Prevalence and Malignancy Risk of Breast Incidental Uptake Detected by PET/CT with Different Radiopharmaceuticals: An Updated Systematic Review and Meta-Analysis. Pharmaceuticals 2025, 18, 1831. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Iacovitti, C.M.; Marin, A.; Tasevski, S.; Martinello, C.; Cuzzocrea, M.; Paone, G.; Rizzo, A.; Albano, D.; Treglia, G. Correction: Iacovitti et al. The Prevalence and Malignancy Risk of Breast Incidental Uptake Detected by PET/CT with Different Radiopharmaceuticals: An Updated Systematic Review and Meta-Analysis. Pharmaceuticals 2025, 18, 1831. Pharmaceuticals 2026, 19, 112. https://doi.org/10.3390/ph19010112

AMA Style

Iacovitti CM, Marin A, Tasevski S, Martinello C, Cuzzocrea M, Paone G, Rizzo A, Albano D, Treglia G. Correction: Iacovitti et al. The Prevalence and Malignancy Risk of Breast Incidental Uptake Detected by PET/CT with Different Radiopharmaceuticals: An Updated Systematic Review and Meta-Analysis. Pharmaceuticals 2025, 18, 1831. Pharmaceuticals. 2026; 19(1):112. https://doi.org/10.3390/ph19010112

Chicago/Turabian Style

Iacovitti, Cesare Michele, Andreea Marin, Slavko Tasevski, Chiara Martinello, Marco Cuzzocrea, Gaetano Paone, Alessio Rizzo, Domenico Albano, and Giorgio Treglia. 2026. "Correction: Iacovitti et al. The Prevalence and Malignancy Risk of Breast Incidental Uptake Detected by PET/CT with Different Radiopharmaceuticals: An Updated Systematic Review and Meta-Analysis. Pharmaceuticals 2025, 18, 1831" Pharmaceuticals 19, no. 1: 112. https://doi.org/10.3390/ph19010112

APA Style

Iacovitti, C. M., Marin, A., Tasevski, S., Martinello, C., Cuzzocrea, M., Paone, G., Rizzo, A., Albano, D., & Treglia, G. (2026). Correction: Iacovitti et al. The Prevalence and Malignancy Risk of Breast Incidental Uptake Detected by PET/CT with Different Radiopharmaceuticals: An Updated Systematic Review and Meta-Analysis. Pharmaceuticals 2025, 18, 1831. Pharmaceuticals, 19(1), 112. https://doi.org/10.3390/ph19010112

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop